We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Merck & Co., Inc.

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional ...

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

Blockbuster weight loss medications from Novo Nordisk ... As for branded products, Merck’s (NYSE:MRK) cancer blockbuster dominates the list, and the checkpoint inhibitor is on track to generate ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster cancer drug, Opdivo.

Merck's biggest cash cow could soon face competition from two drugs in development ... The medicine has an impressive list of approvals in many countries worldwide. It is indicated to treat ...